Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05965687
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2023-06-07
Brief Title:
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke OPENS-3
Sponsor:
Ji XunmingMDPhD
Organization:
Capital Medical University
Study Overview
Official Title:
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke OPENS-3
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the efficacy and safety of Normobaric Hyperoxia combined with intravenous thrombolysis for acute ischemic stroke
Detailed Description:
In this study cases of acute ischemic stroke who undergo intravenous thrombolysis within 45 hours from onset are included The Normobaric HyperoxiaNBO group receive basic intravenous thrombolysis and given 100 oxygen inhalation at a ventilation rate of 10L min using a sealed non-ventilating oxygen storage mask and keep giving oxygen for 4 hours The control group receive basic intravenous thrombolysis and given oxygen inhalation at a ventilation rate of 1Lmin using nasal cannula and keep giving oxygen for 4 hours The investigators aimed to determine the efficacy and safety of Normobaric Hyperoxia combined with intravenous thrombolysis for acute ischemic stroke
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None